Neuralink Receives Health Canada Approval for Groundbreaking Brain Chip Trials
In an exciting development for neurotechnology, Elon Musk's Neuralink has received regulatory approval from Health Canada to initiate its first clinical trial in the country. This trial aims to assess the safety and initial functionality of a brain implant designed to empower individuals with quadriplegia—paralyzed in all four limbs—to control external digital devices simply through their thoughts.
Health Canada has yet to release an official statement regarding this approval. Meanwhile, Neuralink has been making strides in the United States, where devices have been implanted in two patients. The first, Noland Arbaugh, received his Neuralink implant in January and has since demonstrated the device's capabilities by playing video games, browsing the internet, and interacting on social media platforms.
The second participant, who underwent the procedure in August and prefers to remain anonymous, has been utilizing the implant to delve into 3D design and continue gaming. These early successes highlight the potential of Neuralink's technology to significantly enhance the quality of life for individuals with severe mobility impairments.
Reference(s):
Neuralink receives Canadian approval for brain chip implant trials
cgtn.com
